Reap the gains on TFN’s stem cell stock recommendations!
Today's Financial News - Posted January 6, 2009
Each of our recommended 3 hottest stem cell stocks has hit at least 20% gains from our original buy price. Enjoy!
By Laura Cadden, TodaysFinancialNews.com
Baltimore — (TFN): Over a month ago, we told you about the 3 Hottest Stem Cell Stocks under $5.
Our report read, “Even a moderate investment may pay off handsomely if the reinstatement of federal funding triggers the wave of investor interest we expect it to!”
And they sure did.
Today, all have reached at least 20% from our initial buy prices.
HOT STEM CELL STOCK #1: Aastrom Biosciences, Inc. (NASDAQ:ASTM)
Initial buy price = $0.41
Today’s price = $0.59
Gains = 46.34%
HOT STEM CELL STOCK #2: Cerus Corporation (NASDAQ:CERS)
Initial buy price = $0.70
Today’s price = $0.84
Gains = 20%
HOT STEM CELL STOCK #3: Geron Corporation (NASDAQ:GERN)
Initial buy price = $4.14
Today’s price = $5.12
Gains = 23.7%
What to do next depends on your capacity for risk. Each of these stocks has amazing potential…
But there is no denying that these are sweet gains — especially the over 40% for Aastrom!
I recommend you sell your shares of Aastrom Biosciences, Inc. (NASDAQ:ASTM), Cerus Corporation (NASDAQ:CERS), Geron Corporation (NASDAQ:GERN) and enjoy the gains!
Looking for your next stem cell investment? Check out these TFN Special Reports…
- The TFN Complete Guide to Stem Cell Companies Part 1: Share prices above $50
- The TFN Complete Guide to Stem Cell Companies Part 2: Share prices between $10 and $50
- The TFN Complete Guide to Stem Cell Companies Part 3: Share prices between $1 and $10
- The TFN Complete Guide to Stem Cell Companies Part 4: Share prices below $1
Next Article: Hot Stock Confidential: 100%-plus gains on “Options Confidential” beta trade
Be the first to leave a reply.
Your comments are welcome

